Bevacizumab (Avastin) slows the growth of new blood vessels that tumors need to supply themselves with nutrients. Will it work better in combination with the new immunotherapy drug MPDL3280A?
DENVER (September 16, 2014) – The St. Baldrick’s Foundation, a volunteer-driven and donor-centered charity dedicated...
Collaboration between CU Cancer Center and NantBioScience will allow Theodorescu and team to work toward drugs that target Ral protein activation, implicated in nearly a third of all cancers.
A Teal Saturday: Gynecologic Cancer Symposium at CU
September 15, 2014 · No comments
Dressed in teal and enjoying breakfast and visionary talks from leading women’s cancer researchers, 65...
A collaborative study between researchers at the University of Colorado Cancer Center and the National Cancer Institute (NCI) published today in the journal Clinical Cancer Research takes an important step toward defining the genetics of bladder cancer, and implies there may be at least two distinct genetic types of the disease.
AURORA, Colo – On September 10, at the invitation of Rep. Diana DeGette (D) and...
Stand Up To Cancer, Pierce Brosnan and Colorado's HERA Women's Cancer Foundation announce new Dream Team to fight ovarian cancer.
Panel: Time is now for U.S. to lead in biomedical research
September 9, 2014 · No comments
The United States is in danger of losing its biomedical edge to countries that are...
At the CU Cancer Center Fall Retreat 2014, Allen S. Lichter, MD, FASCO, CEO of ASCO, points the way toward the future of oncology in 2030
Bitter melon juice prevents pancreatic cancer in mouse models
September 4, 2014
NTRK1: a new oncogene and target in lung cancer
September 4, 2014
NEJM: Crizotinib Effective in Phase 1 Trial Against ROS1 Lung Cancer
September 30, 2014 · No comments
ALK amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer grants cancer research colorado cancer stem cells Cancer Survivorship clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant james degregori jennifer richer leukemia lung cancer lung cancer research melanoma microRNA ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
CU Cancer Center researcher looks into female sexual health after cancer treatment. “This is a subject that no... fb.me/6OkYVDAdD
Race for the Cure is tomorrow! We hope to see you there! fb.me/6BZ6FkEi0
Did you know that breast cancer is the second leading cause of death in women? Take part in this year's Race for... fb.me/2zSQzD20E